The chip can simulate breathing and lung disease for an individual, holding promise for testing personalized treatments for tuberculosis.
Fate Therapeutics' off-the-shelf cell therapy product platform, including FT819, is gaining significant exposure by being selected for an oral presentation at the prominent EULAR 2025 congress. The ...
With a Kobe University-developed procedure, induced pluripotent stem cells can now be frozen directly in their dishes without ...
A new stem cell–based therapy challenges traditional pain treatment by using pain-sensing neurons to reduce inflammation and protect joints. Newly released preclinical data describes an unconventional ...
MILPITAS, Calif.--(BUSINESS WIRE)--Applied StemCell, an advanced therapeutics CRO/CDMO specializing in iPSCs, gene editing, and small animal models, announced today that it has submitted a Type II ...
iXCells Biotechnologies (“iXCells”) is a leading San Diego, California-based cell technology company focused on generating a wide variety of predictive human disease models. In addition, iXCells is ...
The International Society for Stem Cell Research (ISSCR) today announced the 10 most downloaded papers of 2025 from Stem Cell ...
In this Teach Me in 10, Dr. Philipp Nold, Business Development Manager (Cell and Gene Therapy) at Eppendorf, will explain how ...
Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback